{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:48:16Z","timestamp":1793155696627,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK142751"],"award-info":[{"award-number":["R01DK142751"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10620-026-09779-9","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:26:30Z","timestamp":1773037590000},"page":"3458-3465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn\u2019s Disease"],"prefix":"10.1007","volume":"71","author":[{"given":"Tingyi","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umang","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parakkal","family":"Deepak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SPARC I. B. D. Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themistocles","family":"Dassopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Korzenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Snapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Kudara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Raffals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Beniwal-Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hudesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazer","family":"Ally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauree","family":"Konijeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Matro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Russ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Pekow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushila","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Lidofsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Bewtra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Duerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumona","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Scoville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"9779_CR1","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of Inflammatory Bowel Diseases. New England Journal of Medicine. 2020;383:2652\u20132664. https:\/\/doi.org\/10.1056\/NEJMra2002697.","journal-title":"New England Journal of Medicine."},{"key":"9779_CR2","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A-36A. https:\/\/doi.org\/10.1155\/2005\/269076.","journal-title":"Can J Gastroenterol."},{"key":"9779_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.14309\/ajg.0000000000003465","volume":"120","author":"GR Lichtenstein","year":"2025","unstructured":"Lichtenstein GR, Loftus EV, Afzali A et al. ACG Clinical Guideline: Management of Crohn\u2019s Disease in Adults. Am J Gastroenterol. 2025;120:1225\u20131264. https:\/\/doi.org\/10.14309\/ajg.0000000000003465.","journal-title":"Am J Gastroenterol."},{"key":"9779_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/j.gastro.2023.09.029","volume":"165","author":"AN Ananthakrishnan","year":"2023","unstructured":"Ananthakrishnan AN, Adler J, Chachu KA et al. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn\u2019s Disease. Gastroenterology. 2023;165:1367\u20131399. https:\/\/doi.org\/10.1053\/j.gastro.2023.09.029.","journal-title":"Gastroenterology."},{"key":"9779_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020353","author":"L Alfarone","year":"2022","unstructured":"Alfarone L, Dal Buono A, Craviotto V et al. Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11020353.","journal-title":"J Clin Med"},{"key":"9779_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cgh.2019.11.052","volume":"18","author":"M Allocca","year":"2020","unstructured":"Allocca M, Danese S, Laurent V, Peyrin-Biroulet L. Use of Cross-Sectional Imaging for Tight Monitoring of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18:1309-1323.e4. https:\/\/doi.org\/10.1016\/j.cgh.2019.11.052.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9779_CR7","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1136\/gutjnl-2012-303957","volume":"62","author":"J-M Benitez","year":"2013","unstructured":"Benitez J-M, Meuwis M-A, Reenaers C et al. Role of endoscopy, cross-sectional imaging and biomarkers in Crohn\u2019s disease monitoring. Gut. 2013;62:1806\u20131816. https:\/\/doi.org\/10.1136\/gutjnl-2012-303957.","journal-title":"Gut."},{"key":"9779_CR8","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/gutjnl-2023-329969","volume":"73","author":"A Vich Vila","year":"2024","unstructured":"Vich Vila A, Zhang J, Liu M, Faber KN, Weersma RK. Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases. Gut. 2024;73:1909\u20131920. https:\/\/doi.org\/10.1136\/gutjnl-2023-329969.","journal-title":"Gut."},{"key":"9779_CR9","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41598-025-90160-7","volume":"15","author":"JE Kim","year":"2025","unstructured":"Kim JE, Suh DH, Park YJ et al. Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profiling. Sci Rep. 2025;15:5661.","journal-title":"Sci Rep."},{"key":"9779_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjac149","volume":"17","author":"N Nystr\u00f6m","year":"2023","unstructured":"Nystr\u00f6m N, Prast-Nielsen S, Correia M et al. Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers. J Crohns Colitis. 2023;17:418\u2013432. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac149.","journal-title":"J Crohns Colitis."},{"key":"9779_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ibd\/izad154","volume":"30","author":"L Aldars-Garc\u00eda","year":"2024","unstructured":"Aldars-Garc\u00eda L, Gil-Redondo R, Embade N et al. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Na\u00efve Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2024;30:167\u2013182. https:\/\/doi.org\/10.1093\/ibd\/izad154.","journal-title":"Inflamm Bowel Dis."},{"key":"9779_CR12","doi-asserted-by":"publisher","first-page":"116652","DOI":"10.1016\/j.jpba.2024.116652","volume":"255","author":"NTN Tien","year":"2025","unstructured":"Tien NTN, Choi EJ, Thu NQ et al. An exploratory multi-omics study reveals distinct molecular signatures of ulcerative colitis and Crohn\u2019s disease and their correlation with disease activity. J Pharm Biomed Anal. 2025;255:116652. https:\/\/doi.org\/10.1016\/j.jpba.2024.116652.","journal-title":"J Pharm Biomed Anal."},{"key":"9779_CR13","doi-asserted-by":"publisher","first-page":"106741","DOI":"10.1016\/j.prostaglandins.2023.106741","volume":"168","author":"Y Ben-Mustapha","year":"2023","unstructured":"Ben-Mustapha Y, Ben-Fradj MK, Hadj-Taieb S et al. Altered mucosal and plasma polyunsaturated fatty acids, oxylipins, and endocannabinoids profiles in Crohn\u2019s disease. Prostaglandins Other Lipid Mediat. 2023;168:106741. https:\/\/doi.org\/10.1016\/j.prostaglandins.2023.106741.","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"9779_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","volume":"14","author":"EA Scoville","year":"2018","unstructured":"Scoville EA, Allaman MM, Brown CT et al. Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn\u2019s Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling. Metabolomics. 2018;14:17.","journal-title":"Metabolomics."},{"key":"9779_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/ibd\/izab071","volume":"28","author":"LE Raffals","year":"2022","unstructured":"Raffals LE, Saha S, Bewtra M et al. The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflamm Bowel Dis. 2022;28:192\u2013199. https:\/\/doi.org\/10.1093\/ibd\/izab071.","journal-title":"Inflamm Bowel Dis."},{"key":"9779_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185786","author":"S Kamal","year":"2023","unstructured":"Kamal S, Parkash N, Beattie W, Christensen B, Segal JP. Are We Ready to Reclassify Crohn\u2019s Disease Using Molecular Classification? J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12185786.","journal-title":"J Clin Med."},{"key":"9779_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40168-022-01331-x","volume":"10","author":"CG Gonzalez","year":"2022","unstructured":"Gonzalez CG, Mills RH, Zhu Q et al. Location-specific signatures of Crohn\u2019s disease at a multi-omics scale. Microbiome. 2022;10:133.","journal-title":"Microbiome."},{"key":"9779_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133371","author":"SA Smith","year":"2021","unstructured":"Smith SA, Ogawa SA, Chau L et al. Mitochondrial dysfunction in inflammatory bowel disease alters intestinal epithelial metabolism of hepatic acylcarnitines. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI133371.","journal-title":"J Clin Invest."},{"key":"9779_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/ecco-jcc\/jjaa227","volume":"15","author":"K Gallagher","year":"2021","unstructured":"Gallagher K, Catesson A, Griffin JL, Holmes E, Williams HRT. Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis. 2021;15:813\u2013826. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa227.","journal-title":"J Crohns Colitis."},{"key":"9779_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09557-z","author":"TM Abubasheer","year":"2025","unstructured":"Abubasheer TM, Saad K, Altaweel A et al. Systematic Review of Bile Acids Metabolism in Crohn\u2019s Disease: Implications for Pathogenesis and Therapeutic Interventions. Dig Dis Sci. 2025. https:\/\/doi.org\/10.1007\/s10620-025-09557-z.","journal-title":"Dig Dis Sci."},{"key":"9779_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62:531\u2013539. https:\/\/doi.org\/10.1136\/gutjnl-2012-302578.","journal-title":"Gut."},{"key":"9779_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/00365521.2024.2328592","volume":"59","author":"A Kiasat","year":"2024","unstructured":"Kiasat A, Prast-Nielsen S, Rautiainen S et al. Plasma bile acids in association with Crohn\u2019s disease. Scand J Gastroenterol. 2024;59:674\u2013682. https:\/\/doi.org\/10.1080\/00365521.2024.2328592.","journal-title":"Scand J Gastroenterol."},{"key":"9779_CR23","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41396-019-0560-3","volume":"14","author":"J Connors","year":"2020","unstructured":"Connors J, Dunn KA, Allott J et al. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn\u2019s disease. ISME J. 2020;14:702\u2013713. https:\/\/doi.org\/10.1038\/s41396-019-0560-3.","journal-title":"ISME J."},{"key":"9779_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000350954","volume":"87","author":"V Pittet","year":"2013","unstructured":"Pittet V, Rogler G, Michetti P et al. Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn\u2019s disease. Digestion. 2013;87:212\u2013221. https:\/\/doi.org\/10.1159\/000350954.","journal-title":"Digestion."},{"key":"9779_CR25","doi-asserted-by":"publisher","first-page":"20294","DOI":"10.1038\/s41598-025-07308-8","volume":"15","author":"T Elger","year":"2025","unstructured":"Elger T, Huss M, Liebisch G et al. Elevated long-to-very-long-chain ceramide ratio correlates with disease severity in inflammatory bowel disease and primary sclerosing cholangitis. Sci Rep. 2025;15:20294.","journal-title":"Sci Rep."},{"key":"9779_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09629350210313","volume":"11","author":"FR Homaidan","year":"2002","unstructured":"Homaidan FR, El-Sabban ME, Chakroun I, El-Sibai M, Dbaibo GS. IL-1 stimulates ceramide accumulation without inducing apoptosis in intestinal epithelial cells. Mediators Inflamm. 2002;11:39\u201345. https:\/\/doi.org\/10.1080\/09629350210313.","journal-title":"Mediators Inflamm."},{"key":"9779_CR27","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1111\/jcmm.13267","volume":"21","author":"Y-R Kim","year":"2017","unstructured":"Kim Y-R, Volpert G, Shin K-O et al. Ablation of ceramide synthase 2 exacerbates dextran sodium sulphate-induced colitis in mice due to increased intestinal permeability. J Cell Mol Med. 2017;21:3565\u20133578. https:\/\/doi.org\/10.1111\/jcmm.13267.","journal-title":"J Cell Mol Med."},{"key":"9779_CR28","doi-asserted-by":"publisher","first-page":"2464225","DOI":"10.1080\/19490976.2025.2464225","volume":"17","author":"X Li","year":"2025","unstructured":"Li X, Xiao X, Wang S et al. Uncovering de novo polyamine biosynthesis in the gut microbiome and its alteration in inflammatory bowel disease. Gut Microbes. 2025;17:2464225. https:\/\/doi.org\/10.1080\/19490976.2025.2464225.","journal-title":"Gut Microbes."},{"key":"9779_CR29","doi-asserted-by":"publisher","first-page":"829525","DOI":"10.3389\/fimmu.2022.829525","volume":"13","author":"JP Thomas","year":"2022","unstructured":"Thomas JP, Modos D, Rushbrook SM, Powell N, Korcsmaros T. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease. Front Immunol. 2022;13:829525. https:\/\/doi.org\/10.3389\/fimmu.2022.829525.","journal-title":"Front Immunol."},{"key":"9779_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/ecco-jcc\/jjac173","volume":"17","author":"R Battat","year":"2023","unstructured":"Battat R, Scherl EJ, Lukin D et al. Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease. J Crohns Colitis. 2023;17:795\u2013803. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac173.","journal-title":"J Crohns Colitis."},{"key":"9779_CR31","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.3748\/wjg.v27.i24.3609","volume":"27","author":"Z-H Yang","year":"2021","unstructured":"Yang Z-H, Liu F, Zhu X-R et al. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroenterol. 2021;27:3609\u20133629. https:\/\/doi.org\/10.3748\/wjg.v27.i24.3609.","journal-title":"World J Gastroenterol."},{"key":"9779_CR32","doi-asserted-by":"publisher","first-page":"35039","DOI":"10.1038\/s41598-025-18106-7","volume":"15","author":"S Prast-Nielsen","year":"2025","unstructured":"Prast-Nielsen S, Granstr\u00f6m AL, Kiasat A et al. Associations of the intestinal microbiota with plasma bile acids and inflammation markers in Crohn\u2019s disease and ulcerative colitis. Sci Rep. 2025;15:35039.","journal-title":"Sci Rep."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09779-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:00:43Z","timestamp":1787540443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09779-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9779"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09779-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.D. has received research support under a sponsored research agreement unrelated to the data in the paper and\/or consulting from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Pfizer, Prometheus Biosciences, Takeda Pharmaceuticals, Roche Genentech, Scipher Medicine, Fresenius Kabi, Teva Pharmaceuticals, Landos Pharmaceuticals, Iterative scopes and CorEvitas, LLC. U.J. has received research support unrelated to this manuscript from Boehringer Ingelheim.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board (IRB) at the University of Pennsylvania which is the single IRB for the SPARC IBD study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}